\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ patient\\ was\\ afebrile\\,\\ denied\\ fever\\ or\\ chills\\.\ \(0\)\
\-\ no\\ significant\\ abnormal\\ laboratory\\ values\\ were\\ obtained\\.\ \(0\)\
\-\ treatment\\ options\\ for\\ this\\ patient\\ include\\ percutaneous\\ radiofrequency\\ ablation\\,\\ surgical\\ excision\\ or\\ medical\\ management\\ in\\ hopes\\ of\\ spontaneous\\ regression\\.\\ each\\ of\\ the\\ above\\ have\\ pertinent\\ positive\\ and\\ negative\\ aspects\\ that\\ will\\ be\\ briefly\\ reviewed\\.\ \(0\)\
\-\ \\ \\ \\ \\ \\ currently\\,\\ a\\ percutaneous\\ ablation\\ is\\ the\\ preferred\\ method\\ for\\ treatment\\.\\ \\ percutaneous\\ ablation\\ can\\ be\\ ct\\-guided\\ allowing\\ for\\ a\\ method\\ that\\ is\\ more\\ precise\\,\\ has\\ a\\ high\\ success\\ rate\\,\\ less\\ invasive\\,\\ decreased\\ tissue\\ damage\\,\\ and\\ decreased\\ complications\\.\\ percutaneous\\ ablation\\ of\\ osteoid\\ osteomas\\ is\\ limited\\ when\\ the\\ lesion\\ is\\ juxtaposed\\ to\\ a\\ neurovascular\\ bundle\\ or\\ located\\ in\\ the\\ spine\\ close\\ to\\ the\\ spinal\\ cord\\.\\ surgery\\ may\\ be\\ the\\ preferred\\ method\\ in\\ spinal\\ lesions\\.\\ \ \(0\)\
\-\ concerns\\ with\\ percutaneous\\ ablation\\ is\\ a\\ limited\\ ability\\ to\\ confirm\\ the\\ histology\\ of\\ the\\ lesion\\.\\ ablation\\ is\\ typically\\ via\\ heat\\ and\\ this\\ has\\ a\\ limited\\ range\\ of\\ 10mm\\ spherically\\.\\ therefore\\,\\ ovoid\\ or\\ irregular\\ lesion\\ are\\ more\\ difficult\\ to\\ treat\\ \\(4\\)\\.\ \(0\)\
\-\ surgical\\ treatment\\ is\\ well\\-established\\ with\\ either\\ an\\ en\\-bloc\\ or\\ curettage\\ modality\\.\\ \\ it\\ has\\ a\\ high\\ success\\ rates\\,\\ confirmation\\ of\\ histopathology\\ is\\ possible\\.\\ as\\ stated\\ above\\,\\ surgery\\ for\\ spinal\\ lesions\\ may\\ be\\ preferred\\.\\ concerns\\ with\\ surgical\\ excision\\ is\\ wide\\ exposure\\ techniques\\,\\ more\\ invasive\\ leading\\ to\\ greater\\ tissue\\ damage\\,\\ and\\ delayed\\ recovery\\ \\(4\\)\\.\ \(0\)\
\-\ medical\\ management\\ is\\ based\\ on\\ the\\ inherent\\ nature\\ of\\ osteiod\\ osteoma\\ to\\ spontaneously\\ regress\\.\\ untoward\\ effects\\ of\\ medical\\ management\\ is\\ both\\ the\\ possibility\\ of\\ continuing\\ intense\\ pain\\ and\\ the\\ adverse\\ effects\\ of\\ medication\\ \\(4\\)\\.\ \(0\)\
\-\ after\\ unremarkable\\ radiographs\\ were\\ performed\\,\\ subsequent\\ ct\\ and\\ mri\\ of\\ the\\ femur\\ was\\ performed\\.\ \(0\)\
\-\ a\\ small\\ focal\\ radiolucent\\ lesion\\ found\\ in\\ the\\ distal\\ one\\ third\\ of\\ the\\ femur\\,\\ centered\\ in\\ the\\ cortex\\.\\ \\ subtle\\ reactive\\ sclerosis\\ can\\ be\\ seen\\ on\\ the\\ periphery\\ of\\ the\\ lesion\\.\\ the\\ radiolucency\\ is\\ no\\ greater\\ than\\ 1cm\\ at\\ its\\ longest\\ axis\\.\\ \\ subtle\\ central\\ calcification\\ is\\ present\\.\ \(0\)\
\-\ mild\\ surrounding\\ edema\\.\\ \\ no\\ medullary\\ extension\\.\ \(0\)\
\-\ osteoid\\ osteoma\ \(14\)\
\-\ \\â\\€\\¢\\ ostoid\\ osteoma\ \(0\)\
\-\ \\â\\€\\¢osteomyelitis\ \(0\)\
\-\ \\â\\€\\¢osteoblastoma\ \(0\)\
\-\ \\â\\€\\¢\\ brodie\\ abscess\ \(0\)\
\-\ \\â\\€\\¢\\ eosinophilic\\ granuloma\\/langerhans\\ cell\\ histiocytosis\ \(0\)\
\-\ this\\ 25\\ yo\\ man\\ who\\ presents\\ with\\ worsening\\ left\\ thigh\\ pain\\.\\ pain\\ awakens\\ patient\\ at\\ night\\ and\\ is\\ no\\ longer\\ relieved\\ by\\ naproxen\\.\ \(0\)\
\-\ based\\ on\\ the\\ patient\\ presentation\\,\\ osteoid\\ osteoma\\ was\\ high\\ on\\ the\\ differential\\ and\\ likely\\.\\ the\\ patient\\ was\\ a\\ 25\\ year\\ old\\ male\\.\\ patient\\ are\\ almost\\ exclusively\\ under\\ 30\\ years\\ old\\ and\\ male\\ to\\ female\\ ratio\\ is\\ 2\\-3\\:1\\.\\ he\\ had\\ typical\\ night\\ time\\ pain\\ symptoms\\ and\\ had\\ some\\ relief\\ from\\ naproxen\\.\ \(0\)\
\-\ appearance\\ on\\ imaging\\ is\\ also\\ typical\\ for\\ this\\ entity\\.\\ \\ imaging\\ showed\\ an\\ area\\ of\\ lucency\\ located\\ in\\ the\\ femur\\.\\ the\\ lower\\ extremity\\ is\\ a\\ common\\ location\\ for\\ osteoid\\ osteoma\\.\\ \\ the\\ most\\ common\\ location\\ is\\ in\\ the\\ femoral\\ neck\\ \\(3\\,4\\)\\.\\ \ \(0\)\
\-\ partial\\ relief\\ from\\ naproxen\\ is\\ expected\\.\\ while\\ salicylates\\ classically\\ are\\ described\\ to\\ ameliorate\\ pain\\ symptoms\\,\\ this\\ was\\ not\\ found\\ in\\ this\\ patient\\.\\ cox1\\ \\&\\ 2\\ over\\ expression\\ has\\ been\\ found\\ in\\ the\\ nidus\\ of\\ osteoid\\ osteomas\\ \\(3\\,4\\)\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ablation\\:\\ 0\\.281171016560455\ \(0\)\
\-\ osteoid\\:\\ 0\\.2364581572480152\ \(0\)\
\-\ the\\:\\ 0\\.2310863570726224\ \(0\)\
\-\ osteoma\\:\\ 0\\.22676459278172864\ \(0\)\
\-\ is\\:\\ 0\\.22318545594817937\ \(0\)\
\-\ percutaneous\\:\\ 0\\.20671424545693154\ \(0\)\
\-\ naproxen\\:\\ 0\\.17185769580429713\ \(0\)\
\-\ method\\:\\ 0\\.14187489434880912\ \(0\)\
\-\ preferred\\:\\ 0\\.1365773558633206\ \(0\)\
\-\ of\\:\\ 0\\.12591023412410712\ \(0\)\
\-\ osteomas\\:\\ 0\\.1234113699634039\ \(0\)\
\-\ concerns\\:\\ 0\\.10792718786588669\ \(0\)\
\-\ femur\\:\\ 0\\.10556900894844741\ \(0\)\
\-\ lesion\\:\\ 0\\.10281984755380587\ \(0\)\
\-\ limited\\:\\ 0\\.10270657022652264\ \(0\)\
\-\ patient\\:\\ 0\\.0976571051031519\ \(0\)\
\-\ in\\:\\ 0\\.09603399608402255\ \(0\)\
\-\ management\\:\\ 0\\.09504970013611846\ \(0\)\
\-\ success\\:\\ 0\\.09291056912593422\ \(0\)\
\-\ spinal\\:\\ 0\\.09137109685910885\ \(0\)\
\-\ effects\\:\\ 0\\.08908720718417479\ \(0\)\
\-\ and\\:\\ 0\\.0886336121102343\ \(0\)\
\-\ this\\:\\ 0\\.08843332133660806\ \(0\)\
\-\ be\\:\\ 0\\.08700034681077916\ \(0\)\
\-\ to\\:\\ 0\\.08578578955319907\ \(0\)\
\-\ damage\\:\\ 0\\.08350994518139249\ \(0\)\
\-\ found\\:\\ 0\\.0832616285077184\ \(0\)\
\-\ medical\\:\\ 0\\.08178109397122893\ \(0\)\
\-\ relief\\:\\ 0\\.08045364782725624\ \(0\)\
\-\ has\\:\\ 0\\.07836951392444748\ \(0\)\
\-\ invasive\\:\\ 0\\.07806151471881594\ \(0\)\
\-\ for\\:\\ 0\\.07800365619583337\ \(0\)\
\-\ night\\:\\ 0\\.07706331709634741\ \(0\)\
\-\ pain\\:\\ 0\\.07674388432189394\ \(0\)\
\-\ was\\:\\ 0\\.07474357972151797\ \(0\)\
\-\ or\\:\\ 0\\.07460895784546165\ \(0\)\
\-\ subtle\\:\\ 0\\.07395793815504602\ \(0\)\
\-\ high\\:\\ 0\\.07313310763029839\ \(0\)\
\-\ more\\:\\ 0\\.07065891601645902\ \(0\)\
\-\ spherically\\:\\ 0\\.0685956155278109\ \(0\)\
\-\ ostoid\\:\\ 0\\.0685956155278109\ \(0\)\
\-\ awakens\\:\\ 0\\.0685956155278109\ \(0\)\
\-\ cox1\\:\\ 0\\.0685956155278109\ \(0\)\
\-\ located\\:\\ 0\\.06786025248267909\ \(0\)\
\-\ excision\\:\\ 0\\.06763745221079272\ \(0\)\
\-\ typical\\:\\ 0\\.06629822538804367\ \(0\)\
\-\ osteiod\\:\\ 0\\.06554677269162745\ \(0\)\
\-\ longest\\:\\ 0\\.06554677269162745\ \(0\)\
\-\ salicylates\\:\\ 0\\.06554677269162745\ \(0\)\
\-\ ameliorate\\:\\ 0\\.06554677269162745\ \(0\)\
\-\ on\\:\\ 0\\.06477246126674537\ \(0\)\
\-\ juxtaposed\\:\\ 0\\.0633835842737993\ \(0\)\
\-\ untoward\\:\\ 0\\.0633835842737993\ \(0\)\
\-\ greater\\:\\ 0\\.06320090093888701\ \(0\)\
\-\ surgical\\:\\ 0\\.06254252949472339\ \(0\)\
\-\ based\\:\\ 0\\.062141396495761426\ \(0\)\
\-\ above\\:\\ 0\\.06188778604571636\ \(0\)\
\-\ treatment\\:\\ 0\\.06129696687834959\ \(0\)\
\-\ 25\\:\\ 0\\.060773295277032596\ \(0\)\
\-\ inherent\\:\\ 0\\.060334741437615844\ \(0\)\
\-\ location\\:\\ 0\\.05973572919415966\ \(0\)\
\-\ briefly\\:\\ 0\\.059175625186954954\ \(0\)\
\-\ bundle\\:\\ 0\\.059175625186954954\ \(0\)\
\-\ radiofrequency\\:\\ 0\\.058171553019787686\ \(0\)\
\-\ hopes\\:\\ 0\\.056493653727690336\ \(0\)\
\-\ brodie\\:\\ 0\\.056493653727690336\ \(0\)\
\-\ no\\:\\ 0\\.05579356364056051\ \(0\)\
\-\ radiolucency\\:\\ 0\\.05577698106436895\ \(0\)\
\-\ expression\\:\\ 0\\.05577698106436895\ \(0\)\
\-\ precise\\:\\ 0\\.05452083931728523\ \(0\)\
\-\ regress\\:\\ 0\\.053963593932943345\ \(0\)\
\-\ neurovascular\\:\\ 0\\.05344481089150688\ \(0\)\
\-\ adverse\\:\\ 0\\.05344481089150688\ \(0\)\
\-\ decreased\\:\\ 0\\.05313789670138341\ \(0\)\
\-\ 10mm\\:\\ 0\\.05250366270361465\ \(0\)\
\-\ exclusively\\:\\ 0\\.050914751096759886\ \(0\)\
\-\ performed\\:\\ 0\\.050751552018660176\ \(0\)\
\-\ continuing\\:\\ 0\\.050230700487395474\ \(0\)\
\-\ reviewed\\:\\ 0\\.04960372318158138\ \(0\)\
\-\ lesions\\:\\ 0\\.04926813917879947\ \(0\)\
\-\ nidus\\:\\ 0\\.049025024511237324\ \(0\)\
\-\ are\\:\\ 0\\.04882809208360178\ \(0\)\
\-\ regression\\:\\ 0\\.048751562678931736\ \(0\)\
\-\ allowing\\:\\ 0\\.048751562678931736\ \(0\)\
\-\ common\\:\\ 0\\.04865075091862182\ \(0\)\
\-\ heat\\:\\ 0\\.04751610697417388\ \(0\)\
\-\ curettage\\:\\ 0\\.04729163144960304\ \(0\)\
\-\ symptoms\\:\\ 0\\.04693749335173268\ \(0\)\
\-\ radiolucent\\:\\ 0\\.046861836093409166\ \(0\)\
\-\ entity\\:\\ 0\\.046655813023848455\ \(0\)\
\-\ ability\\:\\ 0\\.04645528456296711\ \(0\)\
\-\ surgery\\:\\ 0\\.04612243122834516\ \(0\)\
\-\ confirmation\\:\\ 0\\.04588391828876051\ \(0\)\
\-\ techniques\\:\\ 0\\.04570271984274828\ \(0\)\
\-\ histology\\:\\ 0\\.04552578528777353\ \(0\)\
\-\ 1cm\\:\\ 0\\.04552578528777353\ \(0\)\
\-\ imaging\\:\\ 0\\.04508368983045571\ \(0\)\
\-\ relieved\\:\\ 0\\.04501866923338386\ \(0\)\
\-\ can\\:\\ 0\\.04501801835803568\ \(0\)\
\-\ tissue\\:\\ 0\\.045001645200962476\ \(0\)\
\-\ classically\\:\\ 0\\.04485695608369421\ \(0\)\
\-\ rates\\:\\ 0\\.044698647675581\ \(0\)\
\-\ centered\\:\\ 0\\.044698647675581\ \(0\)\
\-\ aspects\\:\\ 0\\.04439169192756977\ \(0\)\
\-\ were\\:\\ 0\\.04422044316976109\ \(0\)\
\-\ spontaneously\\:\\ 0\\.04367501926424838\ \(0\)\
\-\ longer\\:\\ 0\\.04367501926424838\ \(0\)\
\-\ pertinent\\:\\ 0\\.04353953142492012\ \(0\)\
\-\ treat\\:\\ 0\\.04340644172678366\ \(0\)\
\-\ histopathology\\:\\ 0\\.04327566674981157\ \(0\)\
\-\ periphery\\:\\ 0\\.04327566674981157\ \(0\)\
\-\ may\\:\\ 0\\.04317045350643257\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.04302074838348366\ \(0\)\
\-\ ratio\\:\\ 0\\.04302074838348366\ \(0\)\
\-\ ovoid\\:\\ 0\\.042774189519565506\ \(0\)\
\-\ had\\:\\ 0\\.04274197029751905\ \(0\)\
\-\ modality\\:\\ 0\\.04241887751716466\ \(0\)\
\-\ stated\\:\\ 0\\.04241887751716466\ \(0\)\
\-\ recovery\\:\\ 0\\.04219100033153461\ \(0\)\
\-\ thigh\\:\\ 0\\.04219100033153461\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.04175497259069624\ \(0\)\
\-\ wide\\:\\ 0\\.041546087724091234\ \(0\)\
\-\ axis\\:\\ 0\\.041443781769836846\ \(0\)\
\-\ exposure\\:\\ 0\\.04076415042104225\ \(0\)\
\-\ each\\:\\ 0\\.040671887034748895\ \(0\)\
\-\ intense\\:\\ 0\\.04049068858873667\ \(0\)\
\-\ confirm\\:\\ 0\\.040140887302334116\ \(0\)\
\-\ possibility\\:\\ 0\\.03988881772241767\ \(0\)\
\-\ medication\\:\\ 0\\.03964492482968259\ \(0\)\
\-\ values\\:\\ 0\\.03956535401685815\ \(0\)\
\-\ chills\\:\\ 0\\.03903075735940797\ \(0\)\
\-\ close\\:\\ 0\\.03881278929663932\ \(0\)\
\-\ denied\\:\\ 0\\.038741515098135115\ \(0\)\
\-\ options\\:\\ 0\\.03867091015081227\ \(0\)\
\-\ expected\\:\\ 0\\.03867091015081227\ \(0\)\
\-\ almost\\:\\ 0\\.038531658548173704\ \(0\)\
\-\ male\\:\\ 0\\.03819543365057242\ \(0\)\
\-\ leading\\:\\ 0\\.0381287386872749\ \(0\)\
\-\ medullary\\:\\ 0\\.03793509609834282\ \(0\)\
\-\ nature\\:\\ 0\\.037871641108747085\ \(0\)\
\-\ therefore\\:\\ 0\\.03780871712947204\ \(0\)\
\-\ spontaneous\\:\\ 0\\.03732342800374125\ \(0\)\
\-\ that\\:\\ 0\\.03722810807421513\ \(0\)\
\-\ afebrile\\:\\ 0\\.03703529422211116\ \(0\)\
\-\ lucency\\:\\ 0\\.03692306271111675\ \(0\)\
\-\ reactive\\:\\ 0\\.036812481723455116\ \(0\)\
\-\ difficult\\:\\ 0\\.0355986788925279\ \(0\)\
\-\ under\\:\\ 0\\.035505845964735085\ \(0\)\
\-\ either\\:\\ 0\\.035459855780737286\ \(0\)\
\-\ via\\:\\ 0\\.03505813209742296\ \(0\)\
\-\ cortex\\:\\ 0\\.03492885604832251\ \(0\)\
\-\ described\\:\\ 0\\.03480176505145601\ \(0\)\
\-\ from\\:\\ 0\\.034070746371581195\ \(0\)\
\-\ with\\:\\ 0\\.03359612412239827\ \(0\)\
\-\ delayed\\:\\ 0\\.03356503649495698\ \(0\)\
\-\ range\\:\\ 0\\.03328521363389617\ \(0\)\
\-\ irregular\\:\\ 0\\.0331154689168969\ \(0\)\
\-\ partial\\:\\ 0\\.03304862961775047\ \(0\)\
\-\ currently\\:\\ 0\\.03294947163169503\ \(0\)\
\-\ complications\\:\\ 0\\.03285160424178835\ \(0\)\
\-\ an\\:\\ 0\\.03280445571643484\ \(0\)\
\-\ worsening\\:\\ 0\\.03275499428357363\ \(0\)\
\-\ ct\\:\\ 0\\.03265971212279643\ \(0\)\
\-\ third\\:\\ 0\\.032659609854735476\ \(0\)\
\-\ rate\\:\\ 0\\.03250327633084719\ \(0\)\
\-\ subsequent\\:\\ 0\\.03247239591108792\ \(0\)\
\-\ at\\:\\ 0\\.03240263332788216\ \(0\)\
\-\ femoral\\:\\ 0\\.03188001321213905\ \(0\)\
\-\ cord\\:\\ 0\\.031795047656782746\ \(0\)\
\-\ its\\:\\ 0\\.031738932682599\ \(0\)\
\-\ laboratory\\:\\ 0\\.03114782068439554\ \(0\)\
\-\ extremity\\:\\ 0\\.030893763692905973\ \(0\)\
\-\ calcification\\:\\ 0\\.03062387146505533\ \(0\)\
\-\ sclerosis\\:\\ 0\\.03055191520644425\ \(0\)\
\-\ extension\\:\\ 0\\.030363331738770857\ \(0\)\
\-\ obtained\\:\\ 0\\.03034008791301903\ \(0\)\
\-\ typically\\:\\ 0\\.030111517985056457\ \(0\)\
\-\ presentation\\:\\ 0\\.02952698485213493\ \(0\)\
\-\ 30\\:\\ 0\\.02926096573214947\ \(0\)\
\-\ less\\:\\ 0\\.029180971662358144\ \(0\)\
\-\ fever\\:\\ 0\\.02908216115188702\ \(0\)\
\-\ possible\\:\\ 0\\.029062553913546174\ \(0\)\
\-\ unremarkable\\:\\ 0\\.028755598165534937\ \(0\)\
\-\ central\\:\\ 0\\.02864364515494401\ \(0\)\
\-\ surrounding\\:\\ 0\\.02860669485138475\ \(0\)\
\-\ showed\\:\\ 0\\.028569925234628327\ \(0\)\
\-\ spine\\:\\ 0\\.028335207903304075\ \(0\)\
\-\ positive\\:\\ 0\\.028264436824243584\ \(0\)\
\-\ differential\\:\\ 0\\.027869943747179632\ \(0\)\
\-\ radiographs\\:\\ 0\\.027819980961079373\ \(0\)\
\-\ area\\:\\ 0\\.027786855922297096\ \(0\)\
\-\ while\\:\\ 0\\.02772104043302945\ \(0\)\
\-\ will\\:\\ 0\\.02760723155450772\ \(0\)\
\-\ abscess\\:\\ 0\\.02754296302956203\ \(0\)\
\-\ some\\:\\ 0\\.02698800351593029\ \(0\)\
\-\ yo\\:\\ 0\\.026797258007227893\ \(0\)\
\-\ negative\\:\\ 0\\.026554906569499784\ \(0\)\
\-\ years\\:\\ 0\\.02629297713353282\ \(0\)\
\-\ neck\\:\\ 0\\.026238977823236247\ \(0\)\
\-\ when\\:\\ 0\\.025909993962056406\ \(0\)\
\-\ appearance\\:\\ 0\\.025858666993869104\ \(0\)\
\-\ abnormal\\:\\ 0\\.025769679308626517\ \(0\)\
\-\ focal\\:\\ 0\\.02565679254325122\ \(0\)\
\-\ likely\\:\\ 0\\.025631935093694498\ \(0\)\
\-\ edema\\:\\ 0\\.025582465364978966\ \(0\)\
\-\ include\\:\\ 0\\.025521082398444868\ \(0\)\
\-\ time\\:\\ 0\\.025423900152110247\ \(0\)\
\-\ he\\:\\ 0\\.02539979958134024\ \(0\)\
\-\ old\\:\\ 0\\.025389342761874534\ \(0\)\
\-\ been\\:\\ 0\\.02499008266603009\ \(0\)\
\-\ distal\\:\\ 0\\.024922033589446713\ \(0\)\
\-\ significant\\:\\ 0\\.024765607141459246\ \(0\)\
\-\ one\\:\\ 0\\.02455838871832427\ \(0\)\
\-\ cell\\:\\ 0\\.024536904784728992\ \(0\)\
\-\ than\\:\\ 0\\.02431495359812332\ \(0\)\
\-\ mild\\:\\ 0\\.02431495359812332\ \(0\)\
\-\ who\\:\\ 0\\.024263059868048914\ \(0\)\
\-\ both\\:\\ 0\\.02391937284821378\ \(0\)\
\-\ over\\:\\ 0\\.023850522659534565\ \(0\)\
\-\ man\\:\\ 0\\.022708209480990293\ \(0\)\
\-\ most\\:\\ 0\\.022322936695963462\ \(0\)\
\-\ small\\:\\ 0\\.022125773548321227\ \(0\)\
\-\ mri\\:\\ 0\\.0220175792839436\ \(0\)\
\-\ present\\:\\ 0\\.02200991036778357\ \(0\)\
\-\ it\\:\\ 0\\.02195644584441821\ \(0\)\
\-\ lower\\:\\ 0\\.021918488309786828\ \(0\)\
\-\ have\\:\\ 0\\.021427522044002938\ \(0\)\
\-\ after\\:\\ 0\\.020808209890320888\ \(0\)\
\-\ female\\:\\ 0\\.020697962708044793\ \(0\)\
\-\ presents\\:\\ 0\\.02063385855472171\ \(0\)\
\-\ seen\\:\\ 0\\.020193786232126126\ \(0\)\
\-\ also\\:\\ 0\\.020175746947241193\ \(0\)\
\-\ by\\:\\ 0\\.01821495391692352\ \(0\)\
\-\ as\\:\\ 0\\.01723173351008768\ \(0\)\
\-\ not\\:\\ 0\\.016933227590632198\ \(0\)\
\-\ left\\:\\ 0\\.014631816867648507\ \(0\)\
\-\ year\\:\\ 0\\.01321884954438681\ \(0\)\
